Radiotherapy for meningiomas
William Chen(University of California, Los Angeles), David R. Raleigh(University of California, San Francisco), Joshua D. Palmer(The Ohio State University), Kanish Mirchia(University of California, San Francisco), Stephen T. Magill(Northwestern University), Haley K. Perlow(University Hospitals Seidman Cancer Center), Abrar Choudhury(University of California, San Francisco), Calixto‐Hope G. Lucas(Johns Hopkins University), Minh Nguyen(University of California, San Francisco), Mark W. Youngblood(Northwestern University)
Cited by 44
Related Papers
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience
|International Journal of Radiation Oncology*Biology*Physics|2005|421
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
|Nature Genetics|2022|296
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
|Nature Neuroscience|2017|247
Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach
|Neurosurgical FOCUS|2018|118
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
|Nature Medicine|2023|104